Topical treatment of inflammatory bowel disease using antibodies and fragments thereof Grant US-11717484-B2 United States of America 08 Aug 2023
Fc-region variants with improved protein A-binding Grant US-11555067-B2 United States of America 17 Jan 2023
FcRn-targeted therapeutics for the treatment of antibody-mediated autoimmune and albumin-me… Grant US-11471526-B2 United States of America 18 Oct 2022
Fc-region variants with modified FcRn-binding and methods of use Grant US-11440971-B2 United States of America 13 Sep 2022
Human FcRn-binding modified antibodies and methods of use Grant AU-2020201429-B2 Australia 16 Jun 2022
METHODS AND REAGENTS FOR MODULATING MACROPHAGE PHENOTYPE Application US-20220031741-A1 United States of America 03 Feb 2022
HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE N/A TW-I747803-B Chinese Taipei 01 Dec 2021
FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE Application EP-3878866-A1 European Patent Office 15 Sep 2021
Human FcRn-binding modified antibodies and methods of use Grant US-11091541-B2 United States of America 17 Aug 2021
FC-REGION VARIANTS WITH IMPROVED PROTEIN A-BINDING Application EP-3842455-A1 European Patent Office 30 Jun 2021
FC-REGION VARIANTS WITH MODIFIED FCRN- AND MAINTAINED PROTEIN A-BINDING PROPERTIES Application EP-3835318-A1 European Patent Office 16 Jun 2021
Fc-region variants with modified FcRn- and protein A-binding properties Grant US-10899846-B2 United States of America 26 Jan 2021
Variant serum albumin with improved half-life and other properties Grant US-10711050-B2 United States of America 14 Jul 2020
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular… Grant US-10683345-B2 United States of America 16 Jun 2020
Fc-region variants with modified FcRn-binding and methods of use Grant US-10683368-B2 United States of America 16 Jun 2020
HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE Application EP-3628685-A1 European Patent Office 01 Apr 2020
FcRn-BINDING ABOLISHED ANTI-IGF-1R ANTIBODIES AND THEIR USE IN THE TREATMENT OF VASCULAR… Application EA-034716-B1 Eurasian Patent Organisation 12 Mar 2020
FC-REGION VARIANTS WITH MODIFIED FCRN-BINDING AND METHODS OF USE Application EP-3611188-A1 European Patent Office 19 Feb 2020
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR… Application EP-3495387-A1 European Patent Office 12 Jun 2019
METHOD FOR INHIBITING ALLERGIC PREDISPOSITION ACQUISITION IN INFANT STAGE THROUGH EFFECT… Application WO-2019093137-A1 World Intellectual Property Organisation (WIPO) 16 May 2019
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODY, NUCLEIC ACID ENCODING THIS ANTIBODY, VECTOR… Application EA-032192-B1 Eurasian Patent Organisation 30 Apr 2019
TOPICAL TREATMENT OF INFLAMMATORY BOWEL DISEASE USING ANTIBODIES AND FRAGMENTS THEREOF Application WO-2018219559-A1 World Intellectual Property Organisation (WIPO) 06 Dec 2018
TOPICAL TREATMENT OF INFLAMMATORY BOWEL DISEASE USING ANTI-TNF-ALPHA ANTIBODIES AND… Application EP-3409688-A1 European Patent Office 05 Dec 2018
FCRN-BINDING ABOLISHED ANTI-IGF-1R ANTIBODIES AND THEIR USE IN THE TREATMENT OF VASCULAR… Application EP-3327034-A1 European Patent Office 30 May 2018
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular… Grant US-9695233-B2 United States of America 04 Jul 2017
Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease Grant US-9499615-B2 United States of America 22 Nov 2016
FC-REGION VARIANTS WITH MODIFIED FCRN-BINDING AND METHODS OF USE Application WO-2016071376-A3 World Intellectual Property Organisation (WIPO) 30 Jun 2016
Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease Grant US-9187559-B2 United States of America 17 Nov 2015
FC-REGION VARIANTS WITH IMPROVED PROTEIN A-BINDING Application WO-2015107015-A1 World Intellectual Property Organisation (WIPO) 23 Jul 2015
FC-REGION VARIANTS WITH MODIFIED FCRN- AND MAINTAINED PROTEIN A-BINDING PROPERTIES Application WO-2015107026-A1 World Intellectual Property Organisation (WIPO) 23 Jul 2015
FC-REGION VARIANTS WITH MODIFIED FCRN-BINDING PROPERTIES Application WO-2015107025-A1 World Intellectual Property Organisation (WIPO) 23 Jul 2015
Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease Grant US-9061005-B2 United States of America 23 Jun 2015
Use of TNFα inhibitor for treatment of psoriasis Grant US-8986693-B1 United States of America 24 Mar 2015
Multiple-variable dose regimen for treating TNFα-related disorders Grant US-8961974-B2 United States of America 24 Feb 2015
Multiple-variable dose regimen for treating TNFα-related disorders Grant US-8961973-B2 United States of America 24 Feb 2015
Multiple-variable dose regimen for treating TNFα-related disorders Grant US-8889136-B2 United States of America 18 Nov 2014
FCRN-BINDING ABOLISHED ANTI-IGF-1R ANTIBODIES AND THEIR USE IN THE TREATMENT OF VASCULAR… Application WO-2014177461-A1 World Intellectual Property Organisation (WIPO) 06 Nov 2014
HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE Application WO-2014177460-A1 World Intellectual Property Organisation (WIPO) 06 Nov 2014
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR… Application WO-2014009465-A1 World Intellectual Property Organisation (WIPO) 16 Jan 2014
ALBUMIN VARIANTS Application WO-2012150319-A1 World Intellectual Property Organisation (WIPO) 08 Nov 2012
ALBUMIN VARIANTS Application WO-2012059486-A1 World Intellectual Property Organisation (WIPO) 10 May 2012